MacroGenics Inc
NASDAQ:MGNX

Watchlist Manager
MacroGenics Inc Logo
MacroGenics Inc
NASDAQ:MGNX
Watchlist
Price: 1.51 USD 0.67% Market Closed
Market Cap: 95.4m USD

Relative Value

The Relative Value of one MGNX stock under the Base Case scenario is 1.86 USD. Compared to the current market price of 1.51 USD, MacroGenics Inc is Undervalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MGNX Relative Value
Base Case
1.86 USD
Undervaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
87
Median 3Y
2.3
Median 5Y
3.8
Industry
7.6
Forward
1.3
vs History
vs Industry
7
Median 3Y
-2.2
Median 5Y
-2.8
Industry
24.3
Forward
-0.7
vs History
vs Industry
1
Median 3Y
-2.5
Median 5Y
-4.2
Industry
22
vs History
vs Industry
1
Median 3Y
-2.4
Median 5Y
-3.9
Industry
24.3
vs History
87
vs Industry
61
Median 3Y
2.1
Median 5Y
2.7
Industry
3.2
vs History
vs Industry
63
Median 3Y
0.6
Median 5Y
1.8
Industry
8.4
Forward
-0.7
vs History
vs Industry
62
Median 3Y
0.6
Median 5Y
1.3
Industry
10.3
vs History
9
vs Industry
19
Median 3Y
-0.6
Median 5Y
-1.7
Industry
6.2
Forward
0.5
vs History
9
vs Industry
18
Median 3Y
-0.6
Median 5Y
-1.6
Industry
6.7
Forward
0.3
vs History
15
vs Industry
18
Median 3Y
-0.7
Median 5Y
-1.8
Industry
8.1
vs History
15
vs Industry
15
Median 3Y
-0.6
Median 5Y
-1.7
Industry
6.6
vs History
vs Industry
44
Median 3Y
1
Median 5Y
2.1
Industry
5.3

Multiples Across Competitors

MGNX Competitors Multiples
MacroGenics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MacroGenics Inc
NASDAQ:MGNX
95.5m USD 0.7 -1.3 0.7 0.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 234 466 -162 711.3 -197 583.5 -195 328.8
US
Abbvie Inc
NYSE:ABBV
413.6B USD 6.9 176.2 17 24.1
US
Amgen Inc
NASDAQ:AMGN
183.9B USD 5.1 26.3 18.8 18.8
US
Gilead Sciences Inc
NASDAQ:GILD
156.4B USD 5.4 19.3 13 13
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
110.6B USD 9.4 30.1 22 23
US
Epizyme Inc
F:EPE
94.1B EUR 2 057.8 -525.1 -571.8 -556.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
75.1B USD 5.3 16.4 15.6 17.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
60.6B USD 24.6 -189.9 -475.2 -326.2
AU
CSL Ltd
ASX:CSL
87.2B AUD 3.6 18.9 12.7 15.9
NL
argenx SE
XBRU:ARGX
48.8B EUR 15.7 36.9 64.1 65.8
P/S Multiple
Revenue Growth P/S to Growth
US
MacroGenics Inc
NASDAQ:MGNX
Average P/S: 3 112 418.2
0.7
-39%
N/A
FR
Pharnext SCA
OTC:PNEXF
34 234 466
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.9
9%
0.8
US
Amgen Inc
NASDAQ:AMGN
5.1
4%
1.3
US
Gilead Sciences Inc
NASDAQ:GILD
5.4
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.4
10%
0.9
US
E
Epizyme Inc
F:EPE
2 057.8
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.3
5%
1.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
24.6
44%
0.6
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
NL
argenx SE
XBRU:ARGX
15.7
46%
0.3
P/E Multiple
Earnings Growth PEG
US
MacroGenics Inc
NASDAQ:MGNX
Average P/E: 46.3
Negative Multiple: -1.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 711.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
176.2
89%
2
US
Amgen Inc
NASDAQ:AMGN
26.3
44%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.3
191%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.1
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -525.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.4
8%
2.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -189.9 N/A N/A
AU
CSL Ltd
ASX:CSL
18.9
11%
1.7
NL
argenx SE
XBRU:ARGX
36.9
37%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
MacroGenics Inc
NASDAQ:MGNX
Average EV/EBITDA: 20.5
0.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 583.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
17
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.8
10%
1.9
US
Gilead Sciences Inc
NASDAQ:GILD
13
7%
1.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -571.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.6
9%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -475.2 N/A N/A
AU
CSL Ltd
ASX:CSL
12.7
8%
1.6
NL
argenx SE
XBRU:ARGX
64.1
769%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
MacroGenics Inc
NASDAQ:MGNX
Average EV/EBIT: 22.4
0.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 328.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
24.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.8
19%
1
US
Gilead Sciences Inc
NASDAQ:GILD
13
13%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -556.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.6
12%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -326.2 N/A N/A
AU
CSL Ltd
ASX:CSL
15.9
11%
1.4
NL
argenx SE
XBRU:ARGX
65.8
N/A N/A